Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss

September 18th, 2003

Nanoparticles May Detect Alzheimer's, Reversal Of Memory Loss

Abstract:
Researchers have discovered for the first time in humans the presence of neurotoxic peptide assemblies that may be responsible for the memory loss found in individuals suffering from Alzheimer's disease (AD). The next step is to develop clinical diagnostics -- using nanoparticles -- to detect the amyloid beta-derived diffusible ligands (ADDLs), and effective drugs that prevent the onset of AD, delay its progression, and potentially restore cognitive function in patients with memory-related disorders, as reported in NanoBiotech News.

Source:
BioExchange

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Arrowhead Pharmaceuticals Hosts R&D Day on Pipeline of RNAi Therapeutics October 17th, 2018

Big award enables study of small surfaces: Rice U.'s Matt Jones wins Packard Fellowship to view nanoscale chemical reactions October 15th, 2018

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-ANG3 October 15th, 2018

180 Degree Capital Corp. Announces New Portfolio Holdings Airgain, Inc., EMCORE Corporation, Lantronix, Inc. and PDL BioPharma, Inc. October 12th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project